The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA75049
Max Phase: Preclinical
Molecular Formula: C14H14N4
Molecular Weight: 238.29
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Cc1[nH]c2ncnc(Nc3ccccc3)c2c1C
Standard InChI: InChI=1S/C14H14N4/c1-9-10(2)17-13-12(9)14(16-8-15-13)18-11-6-4-3-5-7-11/h3-8H,1-2H3,(H2,15,16,17,18)
Standard InChI Key: CGSZHEPJBCJZLG-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 238.29Molecular Weight (Monoisotopic): 238.1218AlogP: 3.32#Rotatable Bonds: 2Polar Surface Area: 53.60Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 5.39CX LogP: 3.26CX LogD: 3.26Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -1.07
References 1. Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N.. (1996) 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase., 39 (12): [PMID:8691423 ] [10.1021/jm960118j ]
